Clinical Trials
10 trialsNCT07328243 2026-01-09
IRE-TCLN
First Affiliated Hospital of Zhejiang University
Phase NA Recruiting
NCT07306273 2025-12-29
IRE Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy
Ruijin Hospital
Phase 2 Recruiting
NCT06451445 2025-12-11
WIRED
University Health Network, Toronto
Phase NA Recruiting
NCT03484299 2025-10-29
Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma
University of Louisville
Phase 1 Recruiting
NCT06205849 2025-07-25
Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas Cancer
University of California, San Diego
Phase 1 Recruiting
NCT04276857 2025-05-13
SMART
University of Saskatchewan
Phase NA Recruiting
NCT05513443 2025-01-20
PRIS
Karolinska Institutet
Phase NA Recruiting
NCT04760327 2024-10-17
GynECT
Institute of Oncology Ljubljana
Phase 2 Recruiting
NCT06185556 2024-08-23
COLDFIRE-III
Amsterdam UMC, location VUmc
Phase 2/3 Recruiting
NCT06491056 2024-07-08
ProAMFocal
Singapore General Hospital
Recruiting